Retrieve available abstracts of 41 articles: HTML format
Single Articles
June 2025
CUNNIFFE NG Extending the role of neurofilament light in multiple sclerosis beyond measuring
irreversible neurodegeneration.
Brain. 2025 Jun 9:awaf224. doi: 10.1093. PubMed
MAUDES E, Planaguma J, Marmolejo L, Radosevic M, et al Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR
encephalitis.
Brain. 2025;148:2023-2037. PubMedAbstract available
May 2025
IRANI SR Models of autoantibody mediated diseases: actively nearing the human gold
standard.
Brain. 2025 May 23:awaf160. doi: 10.1093. PubMed
FENG YF, Zeng ZK, Ni Y, Hu Y, et al Parvalbumin neurons mediate neurological phenotypes of anti-NMDAR encephalitis.
Brain. 2025;148:1652-1664. PubMedAbstract available
GIOVANNONI G, James L, Adeniran AA, Gold J, et al The case for targeting latent and lytic Epstein-Barr virus infection in multiple
sclerosis.
Brain. 2025 May 6:awaf170. doi: 10.1093. PubMedAbstract available
April 2025
NOBILE-ORAZIO E, Cocito D, Manganelli F, Fazio R, et al Rituximab versus placebo for chronic inflammatory demyelinating
polyradiculoneuropathy: a randomized trial.
Brain. 2025;148:1112-1121. PubMedAbstract available
March 2025
THOMMA RCM, Halstead SK, de Koning LC, Wiegers EEJA, et al Large-scale profiling of antibody reactivity to glycolipids in patients with
Guillain-Barre syndrome.
Brain. 2025 Mar 17:awaf102. doi: 10.1093. PubMedAbstract available
January 2025
GIOVANNONI G EBV-specific T-cell responses are telling us something important about multiple
sclerosis.
Brain. 2025 Jan 27:awaf027. doi: 10.1093. PubMed
December 2024
CHEN JQA, McNamara NB, Engelenburg HJ, Jongejan A, et al Distinct transcriptional changes distinguish efficient and poor remyelination in
multiple sclerosis.
Brain. 2024 Dec 24:awae414. doi: 10.1093. PubMedAbstract available
ANDRODIAS G, Lunemann JD, Maillart E, Amato MP, et al De-escalating and discontinuing disease-modifying therapies in multiple
sclerosis.
Brain. 2024 Dec 21:awae409. doi: 10.1093. PubMedAbstract available
COLES A A blood test to predict prognosis in multiple sclerosis?
Brain. 2024;147:3969. PubMed
November 2024
SUN J, Guo M, Chai L, Xu S, et al Distinct virtual histology of grey matter atrophy in four neuroinflammatory
diseases.
Brain. 2024;147:3906-3917. PubMedAbstract available
September 2024
BERGNER CG, van der Meer F, Franz J, Vakrakou A, et al BCAS1-positive oligodendrocytes enable efficient cortical remyelination in
multiple sclerosis.
Brain. 2024 Sep 25:awae293. doi: 10.1093. PubMedAbstract available
August 2024
MONREAL E, Fernandez-Velasco JI, Alvarez-Lafuente R, Sainz de la Maza S, et al Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.
Brain. 2024 Aug 5:awae260. doi: 10.1093. PubMedAbstract available
ZHAO M, Lynch DR, Irani SR Autoimmune 'secondary synaptopathies': do NMDAR antibodies cause a primary
extra-synaptopathy?
Brain. 2024;147:2601-2603. PubMedAbstract available
July 2024
FILIPPI M, Preziosa P, Barkhof F, Ciccarelli O, et al The ageing central nervous system in multiple sclerosis: the imaging perspective.
Brain. 2024 Jul 24:awae251. doi: 10.1093. PubMedAbstract available
HOLM RP, Wandall-Holm MF, Magyari M Multiple sclerosis in Denmark (1950-2023): mean age, sex distribution, incidence
and prevalence.
Brain. 2024 Jul 20:awae245. doi: 10.1093. PubMedAbstract available
TAYLOR BV, Ponsonby AL, Stein M, Lucas R, et al Reply: Putative benefits of vitamin D supplements in multiple sclerosis out of
reach due to sample size.
Brain. 2024 Jul 19:awae246. doi: 10.1093. PubMed
SCHNEIDER-HOHENDORF T, Wunsch C, Falk S, Raposo C, et al Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and
treatment modulation.
Brain. 2024 Jul 18:awae244. doi: 10.1093. PubMedAbstract available
CORSTEN CEA, Wokke BHA, Smolders J Putative benefits of vitamin D supplements in multiple sclerosis out of reach due
to sample size.
Brain. 2024 Jul 16:awae238. doi: 10.1093. PubMed
May 2024
JAMET Z, Mergaux C, Meras M, Bouchet D, et al NMDA receptor autoantibodies primarily impair the extrasynaptic compartment.
Brain. 2024 May 17:awae163. doi: 10.1093. PubMedAbstract available
April 2024
HUANG J, Tengvall K, Bomfim Lima I, Hedstrom AK, et al Genetics of immune response to Epstein-Barr virus: prospects for multiple
sclerosis pathogenesis.
Brain. 2024 Apr 17:awae110. doi: 10.1093. PubMedAbstract available
ARELLANO G, Loda E, Chen Y, Neef T, et al Interferon-gamma controls aquaporin 4-specific Th17 and B cells in neuromyelitis
optica spectrum disorder.
Brain. 2024;147:1344-1361. PubMedAbstract available
March 2024
MAINERO C, Miscioscia A, Treaba CA Cortical remyelination in multiple sclerosis: a target for disease monitoring and
intervention.
Brain. 2024 Mar 27:awae083. doi: 10.1093. PubMed
January 2024
HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al Characterization of cortico-meningeal translocator protein expression in multiple
sclerosis.
Brain. 2024 Jan 30:awae030. doi: 10.1093. PubMedAbstract available
LAZZAROTTO A, Hamzaoui M, Tonietto M, Dubessy AL, et al Time is myelin: early cortical myelin repair prevents atrophy and clinical
progression in multiple sclerosis.
Brain. 2024 Jan 24:awae024. doi: 10.1093. PubMedAbstract available
BAGNATO F, Sati P, Hemond CC, Elliott C, et al Imaging chronic active lesions in multiple sclerosis: a consensus statement.
Brain. 2024 Jan 16:awae013. doi: 10.1093. PubMedAbstract available
SCHWAB N Transcriptomics reveals CSF cellular composition in multiple sclerosis but
detects no viral RNA.
Brain. 2024 Jan 5:awae006. doi: 10.1093. PubMed
QIN C, Chen M, Dong MH, Yang S, et al Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum
disorders.
Brain. 2024;147:163-176. PubMedAbstract available
JAMANN H, Desu HL, Cui QL, Halaweh A, et al ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.
Brain. 2024;147:147-162. PubMedAbstract available
December 2023
MARZIALI LN, Hwang Y, Palmisano M, Cuenda A, et al p38gamma MAPK delays myelination and remyelination and is abundant in multiple
sclerosis lesions.
Brain. 2023 Dec 21:awad421. doi: 10.1093. PubMedAbstract available
CALLEGARI I, Oechtering J, Schneider M, Perriot S, et al Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron
transporter SCARA5.
Brain. 2023 Dec 20:awad424. doi: 10.1093. PubMedAbstract available
CREE BAC Herpes viral infection and the multiple sclerosis prodrome: is HHV-6A infection a
second hit?
Brain. 2023 Dec 18:awad418. doi: 10.1093. PubMed
CLEAVER J, Jeffery K, Klenerman P, Lim M, et al The immunobiology of herpes simplex virus encephalitis and post-viral
autoimmunity.
Brain. 2023 Dec 13:awad419. doi: 10.1093. PubMedAbstract available
BUTZKUEVEN H, Ponsonby AL, Stein MS, Lucas RM, et al Vitamin D did not reduce multiple sclerosis disease activity after a clinically
isolated syndrome.
Brain. 2023 Dec 12:awad409. doi: 10.1093. PubMedAbstract available
BAN M, Bredikhin D, Huang Y, Bonder MJ, et al Expression profiling of cerebrospinal fluid identifies dysregulated antiviral
mechanisms in multiple sclerosis.
Brain. 2023 Dec 1:awad404. doi: 10.1093. PubMedAbstract available
November 2023
KEDDIE S, Smyth D, Keh RYS, Chou MKL, et al Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Brain. 2023;146:4562-4573. PubMedAbstract available
October 2023
GRUT V, Bistrom M, Salzer J, Stridh P, et al Human herpesvirus 6A and axonal injury before the clinical onset of multiple
sclerosis.
Brain. 2023 Oct 31:awad374. doi: 10.1093. PubMedAbstract available
BERNARD HEALEY SA, Giovannoni G, Noyce A, Dobson R, et al Impact of multiple sclerosis risk alleles on the plasma proteome.
Brain. 2023 Oct 18:awad363. doi: 10.1093. PubMed
ALLEN NM, O'Rahelly M, Eymard B, Chouchane M, et al The emerging spectrum of fetal acetylcholine receptor antibody-related disorders
(FARAD).
Brain. 2023;146:4233-4246. PubMedAbstract available
September 2023
MATSUMOTO Y, Kaneko K, Takahashi T, Takai Y, et al Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
Brain. 2023;146:3938-3948. PubMedAbstract available